BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15055992)

  • 21. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
    Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
    Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
    Jeong HJ; Ryu YB; Park SJ; Kim JH; Kwon HJ; Kim JH; Park KH; Rho MC; Lee WS
    Bioorg Med Chem; 2009 Oct; 17(19):6816-23. PubMed ID: 19729316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2008 Apr; 16(7):3839-47. PubMed ID: 18304821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en.
    Honda T; Kubo S; Masuda T; Arai M; Kobayashi Y; Yamashita M
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2938-40. PubMed ID: 19414262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of N-acetyl-6-sulfo-beta-d-glucosaminide-based inhibitors of influenza virus sialidase.
    Sasaki K; Nishida Y; Kambara M; Uzawa H; Takahashi T; Suzuki T; Suzuki Y; Kobayashi K
    Bioorg Med Chem; 2004 Mar; 12(6):1367-75. PubMed ID: 15018909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antiviral activity of substituted bisaryl amide compounds as novel influenza virus inhibitors.
    Hao LH; Li YP; He WY; Wang HQ; Shan GZ; Jiang JD; Li YH; Li ZR
    Eur J Med Chem; 2012 Sep; 55():117-24. PubMed ID: 22824205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2007 Apr; 15(7):2749-58. PubMed ID: 17287121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.
    Li W; Xia L; Hu A; Liu A; Peng J; Tan W
    Arch Pharm (Weinheim); 2013 Sep; 346(9):635-44. PubMed ID: 23926081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
    Liu AL; Wang HD; Lee SM; Wang YT; Du GH
    Bioorg Med Chem; 2008 Aug; 16(15):7141-7. PubMed ID: 18640042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pterocarpans and flavanones from Sophora flavescens displaying potent neuraminidase inhibition.
    Ryu YB; Curtis-Long MJ; Kim JH; Jeong SH; Yang MS; Lee KW; Lee WS; Park KH
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6046-9. PubMed ID: 18938076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.
    Bromba CM; Mason JW; Brant MG; Chan T; Lunke MD; Petric M; Boulanger MJ; Wulff JE
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7137-41. PubMed ID: 22001088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs.
    Wang P; Naduthambi D; Mosley RT; Niu C; Furman PA; Otto MJ; Sofia MJ
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4642-7. PubMed ID: 21704526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity.
    Lew W; Wu H; Chen X; Graves BJ; Escarpe PA; MacArthur HL; Mendel DB; Kim CU
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1257-60. PubMed ID: 10866394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2.
    Butora G; Jiao R; Parsons WH; Vicario PP; Jin H; Ayala JM; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3636-41. PubMed ID: 17482462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of novel thrombin inhibitors. Use of ring-closing metathesis reactions for synthesis of P2 cyclopentene- and cyclohexenedicarboxylic acid derivatives.
    Thorstensson F; Kvarnström I; Musil D; Nilsson I; Samuelsson B
    J Med Chem; 2003 Mar; 46(7):1165-79. PubMed ID: 12646027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.
    Sun J; Mei H
    Chem Biol Drug Des; 2012 May; 79(5):863-8. PubMed ID: 22251826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neuraminidase.
    Lommer BS; Ali SM; Bajpai SN; Brouillette WJ; Air GM; Luo M
    Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1017-23. PubMed ID: 15159560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On three-dimensional holographic vector of atomic interaction field analysis for influenza neuraminidase inhibitors.
    Li ZS; Sun JY; Liang GZ; Lu FL; Zhu WP; Zhang MJ; Zhang Y; Yang SB; Shu M; Chen GH; Lu TT
    Chem Biol Drug Des; 2009 Feb; 73(2):236-43. PubMed ID: 19207426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2beta,3beta-Difluorosialic acid derivatives structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
    Ikeda K; Kitani S; Sato K; Suzuki T; Hosokawa C; Suzuki Y; Tanaka K; Sato M
    Carbohydr Res; 2004 May; 339(7):1367-72. PubMed ID: 15113676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereoselective synthesis and structure-activity relationship of novel ceramide trafficking inhibitors. (1R,3R)-N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide and its analogues.
    Nakamura Y; Matsubara R; Kitagawa H; Kobayashi S; Kumagai K; Yasuda S; Hanada K
    J Med Chem; 2003 Aug; 46(17):3688-95. PubMed ID: 12904073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.